Crescent Grove Advisors’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,286
Closed -$305K 301
2025
Q3
$305K Buy
1,286
+492
+62% +$124K 0.03% 228
2025
Q2
$217K Sell
794
-7
-0.9% -$1.87K 0.02% 262
2025
Q1
$215K Sell
801
-249
-24% -$77.4K 0.02% 249
2024
Q4
$351K Buy
1,050
+203
+24% +$64.8K 0.03% 197
2024
Q3
$232K Sell
847
-445
-34% -$114K 0.02% 254
2024
Q2
$332K Buy
+1,292
New +$346K 0.04% 200
2022
Q3
Sell
-1,344
Closed -$222K 262
2022
Q2
$222K Buy
1,344
+295
+28% +$52.1K 0.02% 236
2022
Q1
$223K Buy
1,049
+245
+30% +$52.7K 0.02% 270
2021
Q4
$204K Buy
+804
New +$226K 0.02% 280
2021
Q3
Sell
-945
Closed -$231K 275
2021
Q2
$231K Sell
945
-180
-16% -$41.5K 0.02% 232
2021
Q1
$238K Buy
+1,125
New +$250K 0.03% 184

Other funds holding CRM

Crescent Grove Advisors's CRM Position: Q4 2025 in Review

Crescent Grove Advisors sold out of Salesforce (CRM) in Q4 2025, closing a stake of 1,286 shares — an estimated $305K sold.

Crescent Grove Advisors first reported a position in CRM in Q1 2021 and held it in 11 quarters. The position peaked at $351K in Q4 2024. 2,948 funds tracked by Wall St. Rank hold CRM as of Q4 2025.

  • Crescent Grove Advisors reported no remaining Salesforce position as of Q4 2025 after selling out during the quarter.
  • Crescent Grove Advisors sold 1,286 Salesforce shares in Q4 2025, an estimated $305K.
  • Crescent Grove Advisors first reported a position in Salesforce in Q1 2021 and held it in 11 quarters.
  • Crescent Grove Advisors's Salesforce position peaked at $351K in Q4 2024.
  • 2,948 funds tracked by Wall St. Rank held Salesforce as of Q4 2025.

Based on Crescent Grove Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.